Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NSTBIO (Nanjing Nstbio) is an active Chinese life science company specializing in supplying fine chemicals, building blocks, chiral ligands, heterocyclic compounds, and pharmaceutical intermediates to pharmaceutical and biotech companies. They offer custom synthesis services for complex organic molecules to support drug discovery efforts globally. Their team includes experienced researchers with advanced degrees in chemistry and biotechnology. The firm also provides contract research services for multi-step syntheses of drug intermediates. Founded in 2011, NSTBIO serves both domestic Chinese clients and international customers with high-quality products from gram to kilogram scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NSTBIO.